The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
The 200 bedded hospital owned & operated by Alexis
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Inducts advanced AI-Powered 24x7 remote patient monitoring system
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
The workshop was conducted as a part of the NITI–State workshop series
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
Arco Lab now holds a 50% stake in Neviton
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
Subscribe To Our Newsletter & Stay Updated
